ˇ
J. Mravljak, S. Pecar / Tetrahedron Letters 50 (2009) 567–569
569
6. Gross, P.; Rimpler, M. Liebigs Ann. Chem. 1986, 1, 37–45.
10. Aspinall, H. C.; Greeves, N.; Lee, W.-M.; McIver, E. G.; Smith, P. M. Tetrahedron
Lett. 1997, 38, 4679–4682.
ˇ
ˇ
7. Babic, A.; Pecar, S. Synth. Commun. 2008, 38, 3052–3061.
8. Hankovszky, H. O.; Hideg, K.; Lex, L. Synthesis 1980, 11, 914–916.
9. Benzyl-4,6-O-benzylidene-2-deoxy-2-stearoylamido-3-O-(1-oxyl-2,2,5,5-tetrame-
11. 2-Deoxy-2-stearoylamido-3-O-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyr-
rol-3-yl)methyl-a-D-glucopyranoside (8): Yellow crystals, mp 102–110 °C. IR
thyl-2,5-dihydro-1H-pyrrol-3-yl)methyl-
crystals, mp 110–112 °C. IR (KBr, cmꢁ1): 3315, 2924, 2854, 1646, 1540,
1456, 1373, 1079. 1H NMR (CDCl3, 300 MHz):
(ppm) 0.88 (t, 3H,
a
-
D-glucopyranoside
(6):
Yellow
(KBr, cmꢁ1): 3310, 2924, 2852, 1642, 1560, 1408, 1262, 1124, 1048. LRMS
(EI), m/z = 599 (M)+. HRMS (ESI), m/z calcd for C33H63N2O7 599.4635 (M)+,
found 599.4652. EPR: aN (ethanol) = 1.513 mT. Calcd C33H63N2O7ꢀ0.5 NH3: C,
65.15; H, 10.69; N, 5.76. Found: C, 65.28; H, 10.69; N, 5.76. HPLC: Column C18
d
J = 6.5 Hz, CH3), 1.15, 1.17 (2s, 12H, cis-, trans-2,5-CH3), 1.25 (br s, 30H,
CH2), 2.12 (t, 2H, J = 7.5 Hz, CO–CH2), 3.60–3.79 (m, 2H, H-6, H-4), 3.86–
3.93 (m, 1H, H-5), 4.05 (app t, 1H, J = 13.7 Hz, H-3), 4.25 (dd, 1H, J = 4.4 Hz,
J = 10.0 Hz, H-6), 4.35–4.38 (m, 1H, H-2), 4.45 (d, 1H, Jgem = 11.8 Hz,
CH2aPh), 4.71 (d, 1H, Jgem = 11.8 Hz, CH2bPh), 4.93 (d, 1H, J = 3.6 Hz, H-1),
5.25 (s, 2H, C–CH2–O), 5.47 (s, 1H, C@CH), 5.55 (s, 1H, CH–Ph), 5.70 (d, 1H,
J = 8.8 Hz, NH),7.18 (s, 1H, N–OH), 7.32–7.48 (m, 10H, H-Ar). 13C NMR
(CDCl3, 75 MHz): d (ppm) 172.47, 141.47, 137.14, 136.76, 129.59, 128.87,
128.29, 128.14, 128.08, 127.89, 125.91, 125.77, 100.98, 97.69, 82.61, 77.19,
69.92, 69.54, 68.92, 68.81, 67.59, 62.96, 52.16, 36.79, 31.80, 29.58, 29.54,
29.40, 29.24, 25.68, 25.58, 24.61, 24.48, 22.57, 14.00. LRMS (EI), m/z = 775.7
(M)+. HRMS (ESI), m/z calcd. for C47H71N2O7 775.5261 (M)+, found 775.5273.
EPR: aN (ethanol) = 1.55 mT. Calcd for C47H71N2O7: C, 72.74; H, 9.22; N,
3.61. Found: C, 73.14; H, 9.42; N, 3.77. NMR spectra were obtained after
reduction of nitroxides to hydroxylamines with phenyl hydrazine
(1.2 equiv) under an argon atmosphere.
Synergy 10
1.0 mL/min; injection volume: 20
l
; mobile phase: gradient 60–90% acetonitrile, water; flow rate
L; retention times: 18.88 min (3.84%),
l
19.44 min (14.22%), 20.00 min (23.36%) and 20.72 min (58.59%) at 210 nm.
12. Rozantsev, E. G. Free Nitroxyl Radicals; Plenum Press: New York, 1970; Plessas,
N. R.; Goldstein, I. J. Carbohydr. Res. 1981, 89, 211–220.
13. Stensrud, G.; Passi, S.; Larsen, T.; Sandset, P. M.; Smistad, G.; Mönkkönen, J.;
Karlsen, J. Int. J. Pharm. 1999, 178, 33–46.
ˇ
14. Mravljak, J.; Zeisig, R.; Pecar, S. J. Med. Chem. 2005, 40, 6393–6399.
15. Multilamellar liposomes were prepared by the lipid film method: gangliosides
(type III) from bovine brain (5.2
and 8 (0.2 mol) were dissolved in 3 mL of chloroform and 1 mL of methanol.
The organic solvents were evaporated on a rotary evaporator in a glass flask,
forming a lipid film and then 180 of a 0.99 M solution of sucrose in
lmol), lecithins (Emulmetic 320) (21.6 lmol)
l
l
L
phosphate buffer saline (PBS, pH 7.4) was added to the flask. The suspension
was hand-shaken and sonicated for 15 min.